Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- The evaluation of new drugs. current Food and Drug Administration regulations and statistical aspects of clinical trials.Arch Intern Med. 1967; 119: 547-556
- Drug monitoring.Academic Press, New York1977
- The discovery of drug induced illness.N Engl J Med. 1977; 296: 481-485
- Postmarketing follow-up.JAMA. 1979; 242: 2310-2314
- Drug evaluation after marketing.Ann Intern Med. 1979; 90: 257-261
- Can postmarketing surveillance help to effect optimal drug therapy?.JAMA. 1979; 242: 2420-2423
- Post-marketing surveillance of new drugs I: review of objectives and methodology.J Clin Pharmacol. 1979; 19: 85-94
Strom BL, Melmon KL, Miettinen OS. Post-marketing studies of drug efficacy: why? Submitted for publication.
- Efficacy of intervention practice: will epidemiology provide the answers?.in: Melmon KL Drug therapeutics—concepts for physician. 2nd ed. Elsevier-North Holland, New York1981: 201-208
- The need for randomization in the study of intended effects.Statistics in Medicine. 1983; 2: 267-271
- Postmarketing studies of drug efficacy: when must they be randomized?.Clin Pharmacol Ther. 1983; 34: 1-7
- Post-menopausal oestrogens protect against fractures of hip and distal radius.Lancet. 1979; II: 705-709
- The risk of hip fracture in post-menopausal females with and without estrogen drug exposure.Am J Public Health. 1981; 71: 138-144
- Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen.N Engl J Med. 1980; 303: 1195-1198
- Improved observational method for studying therapeutic efficacy. Suggestive evidence that lidocaine prophylaxis prevents death in acute myocardial infarction.JAMA. 1981; 246: 2455-2459
- The application of therapeutic trial principles to improve the design of epidemiologic research. A case-control study suggesting that anticoagulants reduce mortality in patients with myocardial infarction.J Chronic Dis. 1981; 34: 575-583
☆This work was supported by a grant from the Joint Commission on Prescription Drug Use, by National Institutes of Health Training Grant GM-07546, and by grants from the Charles A. Dana Foundation, the Rockefeller Foundation, and the Andrew W. Mellon Foundation.